NXF3 and hepatocellular carcinoma: Furthermore, NXF3 was identified to be correlated with the overall and recurrence-free survival time in postoperative patients with HCC, suggesting that NXF3 may be a promising prognostic marker for HCC as well as a novel RNA export pathway for targeting with cancer therapies.